Microglial homeostasis requires balanced CSF-1/CSF-2 receptor signaling
CSF-1R haploinsufficiency causes adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Previous studies in the Csf1r+/- mouse model of ALSP hypothesized a central role of elevated cerebral Csf2 expression. Here we show that monoallelic deletion of Csf2 rescues most behavioral deficits and histopathological changes in Csf1r+/- mice by preventing microgliosis and eliminating most microglial transcriptomic alterations, including those indicative of oxidative stress and demyelination. We also show elevation of Csf2 transcripts and of several CSF-2 downstream targets in the brains of ALSP patients, demonstrating that the mechanisms identified in the mouse model are functional in man. Our data provide new insights into the mechanisms underlying ALSP. Since both increased CSF2 levels and decreased microglial Csf1r expression have also been reported in Alzheimers disease and multiple sclerosis, we suggest that the unbalanced CSF-1R/CSF-2 signaling we describe in the present study may contribute to the pathogenesis of other neurodegenerative conditions. HighlightsO_LIALSP is a CSF1R-deficiency dementia associated with increased CSF2 expression C_LIO_LIIn Csf1r+/- ALSP mice CSF-2 promotes microgliosis by direct signaling in microglia C_LIO_LITargeting Csf2 improves cognition, myelination and normalizes microglial function C_LIO_LICSF-2 is a therapeutic target in ALSP C_LI